OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Fibroblast Growth Factor signaling pathway
David M. Ornitz, Nobuyuki Itoh
Wiley Interdisciplinary Reviews Developmental Biology (2015) Vol. 4, Iss. 3, pp. 215-266
Open Access | Times Cited: 1788
David M. Ornitz, Nobuyuki Itoh
Wiley Interdisciplinary Reviews Developmental Biology (2015) Vol. 4, Iss. 3, pp. 215-266
Open Access | Times Cited: 1788
Showing 1-25 of 1788 citing articles:
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano, Mohanraj Ramachandran, Anna Dimberg
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 9, pp. 1745-1770
Open Access | Times Cited: 1454
Roberta Lugano, Mohanraj Ramachandran, Anna Dimberg
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 9, pp. 1745-1770
Open Access | Times Cited: 1454
FGF/FGFR signaling in health and disease
Yangli Xie, Nan Su, Jing Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 594
Yangli Xie, Nan Su, Jing Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 594
Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
Arun J. Sanyal, Edgar D. Charles, Brent A. Neuschwander‐Tetri, et al.
The Lancet (2018) Vol. 392, Iss. 10165, pp. 2705-2717
Closed Access | Times Cited: 460
Arun J. Sanyal, Edgar D. Charles, Brent A. Neuschwander‐Tetri, et al.
The Lancet (2018) Vol. 392, Iss. 10165, pp. 2705-2717
Closed Access | Times Cited: 460
Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies
Azar Nourian Dehkordi, Fatemeh Mirahmadi Babaheydari, Mohammad Chehelgerdi, et al.
Stem Cell Research & Therapy (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 435
Azar Nourian Dehkordi, Fatemeh Mirahmadi Babaheydari, Mohammad Chehelgerdi, et al.
Stem Cell Research & Therapy (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 435
Developmental pathways in the pathogenesis of lung fibrosis
Diptiman Chanda, Eva Otoupalova, S. Ray Smith, et al.
Molecular Aspects of Medicine (2018) Vol. 65, pp. 56-69
Open Access | Times Cited: 399
Diptiman Chanda, Eva Otoupalova, S. Ray Smith, et al.
Molecular Aspects of Medicine (2018) Vol. 65, pp. 56-69
Open Access | Times Cited: 399
The molecular basis of endothelial cell plasticity
Elisabetta Dejana, Karen K. Hirschi, Michael Simons
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 374
Elisabetta Dejana, Karen K. Hirschi, Michael Simons
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 374
Classifying the evolutionary and ecological features of neoplasms
Carlo C. Maley, Athena Aktipis, Trevor A. Graham, et al.
Nature reviews. Cancer (2017) Vol. 17, Iss. 10, pp. 605-619
Open Access | Times Cited: 373
Carlo C. Maley, Athena Aktipis, Trevor A. Graham, et al.
Nature reviews. Cancer (2017) Vol. 17, Iss. 10, pp. 605-619
Open Access | Times Cited: 373
Fibroblast growth factor signaling in skeletal development and disease
David M. Ornitz, Pierre J. Marie
Genes & Development (2015) Vol. 29, Iss. 14, pp. 1463-1486
Open Access | Times Cited: 353
David M. Ornitz, Pierre J. Marie
Genes & Development (2015) Vol. 29, Iss. 14, pp. 1463-1486
Open Access | Times Cited: 353
FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
Masaru Katoh
International Journal of Molecular Medicine (2016) Vol. 38, Iss. 1, pp. 3-15
Open Access | Times Cited: 342
Masaru Katoh
International Journal of Molecular Medicine (2016) Vol. 38, Iss. 1, pp. 3-15
Open Access | Times Cited: 342
FGF-dependent metabolic control of vascular development
Pengchun Yu, Kerstin Wilhelm, Alexandre Dubrac, et al.
Nature (2017) Vol. 545, Iss. 7653, pp. 224-228
Open Access | Times Cited: 309
Pengchun Yu, Kerstin Wilhelm, Alexandre Dubrac, et al.
Nature (2017) Vol. 545, Iss. 7653, pp. 224-228
Open Access | Times Cited: 309
Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
Yolla Haibe, Malek Kreidieh, Hiba El Hajj, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 301
Yolla Haibe, Malek Kreidieh, Hiba El Hajj, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 301
Fibroblast growth factor receptors as treatment targets in clinical oncology
Masaru Katoh
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 2, pp. 105-122
Closed Access | Times Cited: 300
Masaru Katoh
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 2, pp. 105-122
Closed Access | Times Cited: 300
Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
Yoshiro Itatani, Kenji Kawada, Takamasa Yamamoto, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 4, pp. 1232-1232
Open Access | Times Cited: 283
Yoshiro Itatani, Kenji Kawada, Takamasa Yamamoto, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 4, pp. 1232-1232
Open Access | Times Cited: 283
Advances in covalent kinase inhibitors
Ayah Abdeldayem, Yasir S. Raouf, Stefan N. Constantinescu, et al.
Chemical Society Reviews (2020) Vol. 49, Iss. 9, pp. 2617-2687
Closed Access | Times Cited: 255
Ayah Abdeldayem, Yasir S. Raouf, Stefan N. Constantinescu, et al.
Chemical Society Reviews (2020) Vol. 49, Iss. 9, pp. 2617-2687
Closed Access | Times Cited: 255
Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance
Melanie A. Krook, Julie W. Reeser, Gabrielle Ernst, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 5, pp. 880-892
Open Access | Times Cited: 253
Melanie A. Krook, Julie W. Reeser, Gabrielle Ernst, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 5, pp. 880-892
Open Access | Times Cited: 253
Targeting fibrosis: mechanisms and clinical trials
Manyu Zhao, Liqun Wang, Mengzhu Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 249
Manyu Zhao, Liqun Wang, Mengzhu Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 249
Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors
Shuyan Dai, Zhan Zhou, Zhuchu Chen, et al.
Cells (2019) Vol. 8, Iss. 6, pp. 614-614
Open Access | Times Cited: 242
Shuyan Dai, Zhan Zhou, Zhuchu Chen, et al.
Cells (2019) Vol. 8, Iss. 6, pp. 614-614
Open Access | Times Cited: 242
Syndecans – key regulators of cell signaling and biological functions
Nikolaos A. Afratis, Dragana Nikitovic, Hinke A.B. Multhaupt, et al.
FEBS Journal (2016) Vol. 284, Iss. 1, pp. 27-41
Open Access | Times Cited: 238
Nikolaos A. Afratis, Dragana Nikitovic, Hinke A.B. Multhaupt, et al.
FEBS Journal (2016) Vol. 284, Iss. 1, pp. 27-41
Open Access | Times Cited: 238
Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
Harald Staiger, Michaela Keuper, Lucia Berti, et al.
Endocrine Reviews (2017) Vol. 38, Iss. 5, pp. 468-488
Open Access | Times Cited: 233
Harald Staiger, Michaela Keuper, Lucia Berti, et al.
Endocrine Reviews (2017) Vol. 38, Iss. 5, pp. 468-488
Open Access | Times Cited: 233
Fibroblast growth factors: key players in regeneration and tissue repair
Luigi Maddaluno, Corinne Urwyler, Sabine Werner
Development (2017) Vol. 144, Iss. 22, pp. 4047-4060
Open Access | Times Cited: 225
Luigi Maddaluno, Corinne Urwyler, Sabine Werner
Development (2017) Vol. 144, Iss. 22, pp. 4047-4060
Open Access | Times Cited: 225
Genetic insights into the mechanisms of Fgf signaling
J. Richard Brewer, Pierre Mazot, Philippe Soriano
Genes & Development (2016) Vol. 30, Iss. 7, pp. 751-771
Open Access | Times Cited: 216
J. Richard Brewer, Pierre Mazot, Philippe Soriano
Genes & Development (2016) Vol. 30, Iss. 7, pp. 751-771
Open Access | Times Cited: 216
Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
Wioletta Olejarz, Grażyna Kubiak-Tomaszewska, Alicja Chrzanowska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5840-5840
Open Access | Times Cited: 212
Wioletta Olejarz, Grażyna Kubiak-Tomaszewska, Alicja Chrzanowska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5840-5840
Open Access | Times Cited: 212
Achondroplasia: Development, pathogenesis, and therapy
David M. Ornitz, Laurence Legeai‐Mallet
Developmental Dynamics (2016) Vol. 246, Iss. 4, pp. 291-309
Open Access | Times Cited: 205
David M. Ornitz, Laurence Legeai‐Mallet
Developmental Dynamics (2016) Vol. 246, Iss. 4, pp. 291-309
Open Access | Times Cited: 205
Fibroblasts and myofibroblasts of the intestinal lamina propria in physiology and disease
Manolis Roulis, Richard A. Flavell
Differentiation (2016) Vol. 92, Iss. 3, pp. 116-131
Closed Access | Times Cited: 189
Manolis Roulis, Richard A. Flavell
Differentiation (2016) Vol. 92, Iss. 3, pp. 116-131
Closed Access | Times Cited: 189
Therapeutics Targeting FGF Signaling Network in Human Diseases
Masaru Katoh
Trends in Pharmacological Sciences (2016) Vol. 37, Iss. 12, pp. 1081-1096
Closed Access | Times Cited: 186
Masaru Katoh
Trends in Pharmacological Sciences (2016) Vol. 37, Iss. 12, pp. 1081-1096
Closed Access | Times Cited: 186
